Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

NCT05420597 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05420597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05420597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
April 7, 2021
Completion date
December 31, 2025
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypopharyngeal cancer, laryngeal cancer